on 9 Jul 2018
Last Applicant/ Owned by
BioCryst Pharmaceuticals, Inc.
4505 Emperor Boulevard, Suite 200, Durham
North Carolina, , 27703
Serial Number
UK00801441571 filed on 9th Jul 2018
Registration Number
UK00801441571 registered on
5th Jun 2019
Correspondent Information
Script Intellectual Property LLP
Suite J, Anchor House, School Lane, Chandlers Ford , Eastleigh
Hampshire,
SO53 4DY
Pharmaceuticals for the treatment of infectious, viral inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus, pharmaceuticals for the treatment of transplant rejection; anti-infective pharmaceuticals; pharmaceuticals for the treatment of cancer, namely, cancers of the Immune system such as T-cell and B-cell leukemias and lymphomas.
Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; development of pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus, development of pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases.
UK00801441571
Figurative
Individual